机构:[1]Medical Science and Technology Innovation Center, Institute of Brain Science and Brain7 inspired Research, Shandong Provincial Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China[2]Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China[3]Department of Otorhinolaryngology, Qilu Hospital of Shandong University, NHC Key Laboratory of Otorhinolaryngology (Shandong University), Jinan, 250012, Shandong,[4]State Key Laboratory of Digital Medical Engineering, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, School of Life Sciences and Technology,School of Medicine, Advanced Institute for Life and Health, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, 210096, Jiangsu, China.[5]School of Life Science, Shandong University, Qingdao, 266237, Shandong, China[6]Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, 226001, Jiangsu, China.[7]Department of Neurology, Aerospace Center Hospital, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.[8]Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China,Chengdu, 610072, Sichuan, China.四川省人民医院[9]Southeast University Shenzhen Research Institute, Shenzhen, 518063, Guangdong, China.[10]Department of Cell Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250102, Shandong, China.
National Key R&D Program of China (No. 2019YFA0111400, 2021YFA1101300, 2021YFA1101800, 2020YFA0112503), the National Natural Science Foundation of China (No. 82271175, 82192863, 82001204, 82201294, 82201296, 82301305, 82330033, 82030029, 92149304), the Natural Science Foundation from Shandong Province (No. ZR2022QH338, ZR2021QH269, ZR2022QH205), Science and Technology Department of Sichuan Province (No. 2021YFS0371), Shenzhen Science and Technology Program (JCYJ20190814093401920, JCYJ20210324125608022), 2022 722 Open Project Fund of Guangdong Academy of Medical Sciences (YKY-KF202201).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|1 区医学
小类|1 区生物工程与应用微生物1 区遗传学1 区医学:研究与实验
JCR分区:
出版当年[2024]版:
无
最新[2023]版:
Q1BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ1GENETICS & HEREDITYQ1MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Medical Science and Technology Innovation Center, Institute of Brain Science and Brain7 inspired Research, Shandong Provincial Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China
共同第一作者:
通讯作者:
通讯机构:[2]Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China[4]State Key Laboratory of Digital Medical Engineering, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, School of Life Sciences and Technology,School of Medicine, Advanced Institute for Life and Health, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, 210096, Jiangsu, China.[6]Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, 226001, Jiangsu, China.[7]Department of Neurology, Aerospace Center Hospital, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.[8]Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China,Chengdu, 610072, Sichuan, China.[9]Southeast University Shenzhen Research Institute, Shenzhen, 518063, Guangdong, China.
推荐引用方式(GB/T 7714):
Liu Ziyi,Zhang Hanbing,Hong Guodong,et al.Inhibition of Gpx4-mediated Ferroptosis Alleviates Cisplatin-Induced Hearing Loss in C57BL/6 mice[J].Molecular Therapy : The Journal Of The American Society Of Gene Therapy.2024,32(5):1387-1406.doi:10.1016/j.ymthe.2024.02.029.
APA:
Liu Ziyi,Zhang Hanbing,Hong Guodong,Bi Xiuli,Hu Jun...&Fu Xiaolong.(2024).Inhibition of Gpx4-mediated Ferroptosis Alleviates Cisplatin-Induced Hearing Loss in C57BL/6 mice.Molecular Therapy : The Journal Of The American Society Of Gene Therapy,32,(5)
MLA:
Liu Ziyi,et al."Inhibition of Gpx4-mediated Ferroptosis Alleviates Cisplatin-Induced Hearing Loss in C57BL/6 mice".Molecular Therapy : The Journal Of The American Society Of Gene Therapy 32..5(2024):1387-1406